The multidrug resistance (MDR) of cancer cells includes a modified apoptosis pathway and an overexpression of multidrug transporters, such as p-glycoprotein (P-gp), which comprises one of the most important problems to overcome in cancer treatment. This evidence concerns the gene ABCB1 and cancer.